How much is Wugen worth in 2026?

Wugen has a current valuation of $245.0M based on their Later Stage VC round and secondary market data.

How much funding has Wugen raised?

Wugen has raised $323.0M in total funding across 2 funding rounds.

Wugen

Drug DiscoveryWebsite

Wugen valuation and funding history | Last updated: August 27, 2025 | 2 funding rounds

Current Valuation

$245.0M

As of August 27, 2025

Total Funding Raised

$323.0M

Across 2 rounds

Last Round

Later Stage VC

$115.0M

Last Funding

Aug 2025

Funding date

Capital Efficiency

0.76x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 27, 2025	Later Stage VC (Series C)	$115.0M	N/A	-
December 16, 2022	Early Stage VC (Series B)	$172.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Wugen is currently valued at $245.0M as of August 27, 2025. The company has raised a total of $323.0M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 0.76x, Wugen has achieved a valuation that is 0.76 times the total capital raised.

Track Wugen Valuation Updates

Get notified when Wugen raises new funding or valuation changes

Explore More Data

Detailed analysis for Wugen

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Wugen's valuation history, funding rounds, and growth metrics.

No credit card required

What is Wugen Worth in 2026?

Wugen is a leading private company in the Drug Discovery sector. Track Wugen's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Wugen Valuation is Determined

Private company valuations like Wugen's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.